For every woman who receives a breast cancer diagnosis, the initial shock is followed by a steep learning curve. How to choose the right doctor, how to decide on the best treatment plan, where to find promising clinical trials, and how to manage both the physical and emotional fallout of the disease – all of it is daunting.

When she was younger, before the kids came along, Cindy Howard was a savvy, enthusiastic traveler. She would skip from one exotic locale to another, spending months at a time away from home and loving every minute of it.

Breast Cancer Awareness Month is a great reminder of just how far the fight against breast cancer has come. It is still one of the most common cancers among women, yet more women than ever are surviving the disease. Today, there are an estimated 2.8 million breast cancer survivors in the United States.

A new spin on a tried-and-true imaging system could potentially provide more women with superior breast cancer detection at a lower cost.

When it comes to research into the treatment of hematologic cancers, City of Hope scientists stand out. One study that  they presented this week at the annual meeting of the American Society of Hematology suggests a new standard of care for HIV-associated lymphoma, another offers promise for the treatment of relapsing or treatment-resistant lymphoma, and still another points to more effective treatment for acute lymphoblastic leukemia.